Microbial influences in inflammatory bowel diseases.
暂无分享,去创建一个
[1] S. Kane,et al. Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.
[2] D. Huso,et al. Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis , 2007, Inflammatory bowel diseases.
[3] C. Jobin,et al. Dual‐association of gnotobiotic Il‐10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis , 2007, Inflammatory bowel diseases.
[4] D. Hommes,et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.
[5] T. Klaenhammer,et al. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[6] H. Clevers,et al. The Paneth Cell α-Defensin Deficiency of Ileal Crohn’s Disease Is Linked to Wnt/Tcf-41 , 2007, The Journal of Immunology.
[7] C. Pothoulakis,et al. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. , 2007, Gastroenterology.
[8] D. Haller,et al. Bacteria‐ and host‐derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammation , 2007, Inflammatory bowel diseases.
[9] Martin Wiedmann,et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.
[10] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[11] B. Finlay,et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.
[12] H. Wexler,et al. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. , 2007, Microbial pathogenesis.
[13] P. Gerner-Smidt,et al. Invasive Escherichia coli are a feature of Crohn's disease , 2007, Laboratory Investigation.
[14] A. Sharafkhaneh,et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. , 2007, Immunity.
[15] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[16] U. Göbel,et al. Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.
[17] K. Whelan,et al. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials , 2007, Proceedings of the Nutrition Society.
[18] D. Kalman,et al. TLR Signaling Mediated by MyD88 Is Required for a Protective Innate Immune Response by Neutrophils to Citrobacter rodentium1 , 2007, The Journal of Immunology.
[19] J. Hugot,et al. CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice , 2007, PloS one.
[20] W. Selby,et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.
[21] D. Podolsky,et al. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[22] N. Barnich,et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. , 2007, The Journal of clinical investigation.
[23] C. Jobin,et al. Gnotobiotic IL-10−/−;NF-κBEGFP Mice Reveal the Critical Role of TLR/NF-κB Signaling in Commensal Bacteria-Induced Colitis1 , 2007, The Journal of Immunology.
[24] S. Targan,et al. Anti‐flagellin (CBir1) phenotypic and genetic Crohn's disease associations , 2007, Inflammatory bowel diseases.
[25] C. Elson,et al. CCFA Microbial–Host Interactions Workshop: Highlights and key observations , 2007, Inflammatory bowel diseases.
[26] Judy H Cho,et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.
[27] S. Nuding,et al. Reduced mucosal antimicrobial activity in Crohn’s disease of the colon , 2007, Gut.
[28] A. Lobo,et al. A case-control study of drinking water and dairy products in Crohn's Disease--further investigation of the possible role of Mycobacterium avium paratuberculosis. , 2007, American journal of epidemiology.
[29] A. Gruber,et al. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.
[30] M. Neurath,et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.
[31] Nathalie Rolhion,et al. OmpC and the σE regulatory pathway are involved in adhesion and invasion of the Crohn's disease‐associated Escherichia coli strain LF82 , 2007, Molecular microbiology.
[32] Kimberly A. Reske,et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] Dawn B. Beaulieu,et al. Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] F. Shanahan,et al. Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.
[35] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[36] F. Cominelli,et al. Commensal Bacteria Exacerbate Intestinal Inflammation but Are Not Essential for the Development of Murine Ileitis1 , 2007, The Journal of Immunology.
[37] H. Ogata,et al. Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis Patients , 2007, The American Journal of Gastroenterology.
[38] S. Targan,et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. , 2007, Gastroenterology.
[39] E. Vicaut,et al. Risk Factors for Intra-Abdominal Septic Complications After a First Ileocecal Resection for Crohn’s Disease: A Multivariate Analysis in 161 Consecutive Patients , 2007, Diseases of the colon and rectum.
[40] S. Brant,et al. Testing the Interaction between NOD-2 Status and Serological Response to Mycobacterium paratuberculosis in Cases of Inflammatory Bowel Disease , 2007, Journal of Clinical Microbiology.
[41] D. Relman,et al. The role of microbes in Crohn's disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] I. Wilson,et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.
[43] J. Korzenik. Is Crohn’s disease due to defective immunity? , 2006, Gut.
[44] U Wahnschaffe,et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.
[45] N. Barnich,et al. Adherent-invasive Escherichia coli and Crohn's disease , 2007, Current opinion in gastroenterology.
[46] J. Doré,et al. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis , 2006, Gut.
[47] A. Ebringer,et al. A possible link between Crohn’s disease and ankylosing spondylitis via Klebsiella infections , 2007, Clinical Rheumatology.
[48] Thomas Lengauer,et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.
[49] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[50] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[51] J. Garcia-Gil,et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.
[52] S. Targan,et al. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease , 2006, Inflammatory bowel diseases.
[53] S. Cucchiara,et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.
[54] M. Gazouli,et al. Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. , 2006, World journal of gastroenterology.
[55] Yu-Tseung Liu,et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells , 2006, Nature Cell Biology.
[56] J. Goldblum,et al. Clostridium Difficile-Associated Pouchitis , 2006, Digestive Diseases and Sciences.
[57] M. Kleerebezem,et al. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase , 2006, Inflammatory Bowel Diseases.
[58] Shadi Sepehri,et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.
[59] J. Sillanpää,et al. Endocarditis and biofilm-associated pili of Enterococcus faecalis. , 2006, The Journal of clinical investigation.
[60] M. Behr,et al. Mycobacteria in Crohn's disease: a persistent hypothesis. , 2006, Inflammatory bowel diseases.
[61] H. Steinhart,et al. Antibiotic therapy for Crohn's disease: a review. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[62] F. Shanahan,et al. Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.
[63] U. Gophna,et al. Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.
[64] Bernhard Radlwimmer,et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. , 2006, American journal of human genetics.
[65] R. Xu,et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.
[66] G. Gazelle,et al. Risks and benefits of infliximab for the treatment of Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[67] F. Powrie,et al. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.
[68] R. Bibiloni,et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.
[69] J. Harel,et al. Adherent and Invasive Escherichia coli Is Associated with Granulomatous Colitis in Boxer Dogs , 2006, Infection and Immunity.
[70] D. Haller,et al. IL‐10 Gene‐Deficient Mice Lack TGF‐Beta/Smad‐Mediated TLR2 Degradation and Fail to Inhibit Proinflammatory Gene Expression in Intestinal Epithelial Cells under Conditions of Chronic Inflammation , 2006, Annals of the New York Academy of Sciences.
[71] J. Meijerink,et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.
[72] R. Sartor. Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[73] M. Pop,et al. Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.
[74] Erik Remaut,et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[75] A. Baldwin,et al. Wound‐induced p38MAPK‐dependent histone H3 phosphorylation correlates with increased COX‐2 expression in enterocytes , 2006, Journal of cellular physiology.
[76] J. Mallet,et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. , 2006, Gastroenterology.
[77] A. Rahbar,et al. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease , 2006, Journal of Autoimmunity.
[78] J. Valentine,et al. Inhibition of phagosome maturation and survival of Mycobacterium avium subspecies paratuberculosis in polymorphonuclear leukocytes from Crohn's disease patients. , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[79] S. Targan,et al. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. , 2006, Gastroenterology.
[80] S. Deventer,et al. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study , 2006, Alimentary pharmacology & therapeutics.
[81] Klaus Ley,et al. The primary defect in experimental ileitis originates from a nonhematopoietic source , 2006, The Journal of experimental medicine.
[82] J. Galanko,et al. T cell‐mediated oral tolerance is intact in germ‐free mice , 2006, Clinical and experimental immunology.
[83] M. Camilleri,et al. Recommendations for probiotic use. , 2006, Journal of clinical gastroenterology.
[84] K. Rioux,et al. Probiotics in the treatment of inflammatory bowel disease. , 2006, Journal of clinical gastroenterology.
[85] William D. Lees,et al. Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.
[86] R. Ley,et al. Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.
[87] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[88] Dennis Christie,et al. Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression , 2006, The American Journal of Gastroenterology.
[89] P. Rutgeerts,et al. Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases , 2006, Inflammatory bowel diseases.
[90] N. Rao,et al. Abundant and Diverse Fungal Microbiota in the Murine Intestine , 2006, Applied and Environmental Microbiology.
[91] H. Nagawa,et al. Cytomegalovirus infection in ulcerative colitis , 2006, Scandinavian journal of gastroenterology.
[92] C. Hawkey,et al. Probiotics for maintenance of remission in Crohn's disease. , 2006, The Cochrane database of systematic reviews.
[93] A. Forbes,et al. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? , 2003, Gastroenterology.
[94] Tatsuo Yamamoto,et al. Change in the bacterial flora of pouchitis. , 2006, Hepato-gastroenterology.
[95] Tomohiro Watanabe,et al. Signalling pathways and molecular interactions of NOD1 and NOD2 , 2006, Nature Reviews Immunology.
[96] A. Gewirtz,et al. Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[97] M. Weichenthal,et al. Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .
[98] C. Ackerley,et al. Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31. , 2005, Biochemical and biophysical research communications.
[99] M. Gottfried,et al. Piroxicam Treatment of Il‐10‐Deficient Mice Enhances Colonic Epithelial Apoptosis and Mucosal Exposure to Intestinal Bacteria , 2005, Inflammatory bowel diseases.
[100] J. Sundberg,et al. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. , 2005, Gastroenterology.
[101] H. Redmond,et al. A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[102] M. Gazouli,et al. Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead , 2005, Journal of Clinical Microbiology.
[103] Ping-Chang Yang,et al. Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis , 2005, BMC gastroenterology.
[104] S. Akira,et al. Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium‐induced colitis in Toll‐like receptor 4 knockout mice , 2005, Clinical and experimental immunology.
[105] R. Balicer,et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.
[106] M. Zeitz,et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.
[107] S. Targan,et al. Defects in mucosal immunity leading to ulcerative colitis , 2005, Immunological reviews.
[108] P. Rutgeerts,et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. , 2005, The New England journal of medicine.
[109] H. Lochs,et al. Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.
[110] R. Bibiloni,et al. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE , 2005, Letters in applied microbiology.
[111] T. Giese,et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease , 2005, Gut.
[112] G. Rogler,et al. Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn’s disease , 2005, Gut.
[113] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[114] R. Sartor,et al. Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? , 2005, Gut.
[115] S. Targan,et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.
[116] W. Schmiegel,et al. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. , 2005, European journal of medical research.
[117] R. Xu,et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[118] P. Rutgeerts,et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. , 2005, Gastroenterology.
[119] R. Sartor,et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. , 2005, Gastroenterology.
[120] N. Barnich,et al. Strong Decrease in Invasive Ability and Outer Membrane Vesicle Release in Crohn's Disease-Associated Adherent-Invasive Escherichia coli Strain LF82 with the yfgL Gene Deleted , 2005, Journal of bacteriology.
[121] L. Eckmann,et al. Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .
[122] H. Lochs,et al. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. , 2005, World journal of gastroenterology.
[123] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[124] H. Drummond,et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. , 2005, Gastroenterology.
[125] C. Jobin,et al. STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .
[126] J. Orenstein,et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. , 2005, The Journal of clinical investigation.
[127] T. Ohkusa,et al. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up , 2005, Scandinavian journal of gastroenterology.
[128] T. Giese,et al. Expression of Interleukin‐12‐Related Cytokine Transcripts in Inflammatory Bowel Disease: Elevated Interleukin‐23p19 and Interleukin‐27p28 in Crohn's Disease But Not in Ulcerative Colitis , 2005, Inflammatory bowel diseases.
[129] R. Chiodini,et al. Possible role of mycobacteria in inflammatory bowel disease , 1984, Digestive Diseases and Sciences.
[130] T. Hirayama,et al. This information is current as Signaling in Intestinal Epithelial Cells-Defensin-2 Expression Is Regulated by TLR β and , 2004 .
[131] M. Stolte,et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.
[132] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[133] Tomohiro Watanabe,et al. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.
[134] F. Shanahan,et al. Bacterial DNA within Granulomas of Patients with Crohn's Disease—Detection by Laser Capture Microdissection and PCR , 2004, American Journal of Gastroenterology.
[135] G. Greenberg,et al. High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study , 2004, Digestive Diseases and Sciences.
[136] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[137] L. Mayer,et al. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. , 2004, Gastroenterology.
[138] S. Targan,et al. Bacterial flagellin is a dominant antigen in Crohn disease , 2004 .
[139] W. Harmsen,et al. Early Postoperative Complications are not Increased in Patients with Crohn's Disease Treated Perioperatively with Infliximab or Immunosuppressive Therapy , 2004, American Journal of Gastroenterology.
[140] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[141] M. Karin,et al. IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium , 2004 .
[142] W. Mow,et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.
[143] F. Seibold,et al. pANCA Represents a Cross-Reactivity to Enteric Bacterial Antigens , 1998, Journal of Clinical Immunology.
[144] R. Sartor,et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin , 1993, Inflammation.
[145] A. Zinsmeister,et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. , 2004, Gastroenterology.
[146] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.
[147] H. Harmsen,et al. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice , 2003, Gut.
[148] M. Neurath,et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.
[149] S. Davies,et al. Crohn's disease and the NOD2 gene: a role for paneth cells. , 2003, Gastroenterology.
[150] R. Schwabe,et al. Transforming Growth Factor- (cid:1) 1 Inhibits Non-pathogenic Gram-negative Bacteria-induced NF- (cid:2) B Recruitment to the Interleukin-6 Gene Promoter in Intestinal Epithelial Cells through Modulation of Histone Acetylation* , 2022 .
[151] D. Podolsky,et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.
[152] C. Elson,et al. Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1 , 2002, The Journal of Immunology.
[153] C. Neut,et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.
[154] Mark M Huycke,et al. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. , 2002, Carcinogenesis.
[155] H. Buhr,et al. Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls , 2002, Scandinavian journal of gastroenterology.
[156] Manfred Dietel,et al. Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.
[157] S. Kitajima,et al. Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. , 2001, Experimental animals.
[158] Sinead B. O'Leary,et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.
[159] Jean-Frederic Colombel,et al. Adherent Invasive Escherichia coli Strains from Patients with Crohn's Disease Survive and Replicate within Macrophages without Inducing Host Cell Death , 2001, Infection and Immunity.
[160] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[161] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[162] J. Gordon,et al. Commensal Host-Bacterial Relationships in the Gut , 2001, Science.
[163] J. Schölmerich,et al. Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice , 2001, Infection and Immunity.
[164] R. Sartor,et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. , 2001, Gastroenterology.
[165] J. Boudeau,et al. Type 1 pili‐mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells , 2001, Molecular microbiology.
[166] J. Gordon,et al. Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.
[167] A. Young,et al. Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination , 2000 .
[168] W. Fiers,et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.
[169] P. Brigidi,et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[170] S. Naser,et al. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients , 2000, American Journal of Gastroenterology.
[171] K. Madsen,et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. , 1999, Inflammatory bowel diseases.
[172] V. Godfrey,et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[173] K. Wilson,et al. Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized with Bacteroides vulgatus or Escherichia coli , 1999, Infection and Immunity.
[174] J. Cebra,et al. Influences of microbiota on intestinal immune system development. , 1999, The American journal of clinical nutrition.
[175] G. Kollias,et al. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.
[176] N. Barnich,et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.
[177] J. C. Jones,et al. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. , 1998, Journal of immunology.
[178] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[179] J. Sundberg,et al. CD4+ T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease , 1998, The Journal of experimental medicine.
[180] F. Guarner,et al. Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. , 1998, Gastroenterology.
[181] P. Rutgeerts,et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.
[182] J. Macfie,et al. Microbiology of bacterial translocation in humans , 1998, Gut.
[183] M. Kagnoff,et al. Epithelial cells as sensors for microbial infection. , 1997, The Journal of clinical investigation.
[184] J. Sanderson,et al. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. , 1997, The Journal of antimicrobial chemotherapy.
[185] M. Fishman,et al. Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.
[186] P. Katsel,et al. On the etiology of Crohn disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[187] J. Sanderson,et al. IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales , 1996, Applied and environmental microbiology.
[188] R. Hammer,et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.
[189] R. Hilsden,et al. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.
[190] I. Forgacs,et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. , 1996, Gut.
[191] K. Ewe,et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.
[192] J. Gordon,et al. Inflammatory Bowel Disease and Adenomas in Mice Expressing a Dominant Negative N-Cadherin , 1995, Science.
[193] P. Rutgeerts,et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. , 1995, Gastroenterology.
[194] A. West,et al. Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease , 1995, Gastroenterology.
[195] C. Elson,et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.
[196] R. Hammer,et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.
[197] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[198] B. Rowlands,et al. Colonic bacteria and bacterial translocation in experimental colitis , 1993, The British journal of surgery.
[199] Van Kruiningen Hj,et al. An immunocytochemical search for infectious agents in Crohn's disease. , 1993 .
[200] W. Roediger,et al. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. , 1993, Gastroenterology.
[201] R. Chiodini,et al. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities , 1989, Clinical Microbiology Reviews.
[202] R. Sartor,et al. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury , 1988, Infection and immunity.
[203] M. Broom,et al. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. , 1988, Gastroenterology.
[204] J. Rotter,et al. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.
[205] W. J. Cromartie,et al. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. , 1985, Gastroenterology.
[206] M. Keighley,et al. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery , 1984, The British journal of surgery.
[207] M. Keighley,et al. Incidence and microbiology of abdominal and pelvic abscess in Crohn's disease. , 1982, Gastroenterology.
[208] J. Mcghee,et al. Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. , 1982, Journal of immunology.
[209] M. Kagnoff. On the etiology of Crohn's disease. , 1978, Gastroenterology.